|
SENP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.444200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.510330E-02 |
| Normal-vs-Stage2 |
1.754020E-02 |
| Normal-vs-Stage3 |
1.638280E-03 |
| Normal-vs-Stage4 |
4.540800E-03 |
| Stage1-vs-Stage2 |
5.939400E-01 |
| Stage1-vs-Stage3 |
2.209200E-01 |
| Stage1-vs-Stage4 |
4.120200E-01 |
| Stage2-vs-Stage3 |
7.327000E-01 |
| Stage2-vs-Stage4 |
8.276400E-01 |
| Stage3-vs-Stage4 |
9.082200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.703200E-03 |
| Normal-vs-AfricanAmerican |
3.557600E-01 |
| Normal-vs-Asian |
5.522800E-03 |
| Caucasian-vs-AfricanAmerican |
3.183600E-01 |
| Caucasian-vs-Asian |
6.258400E-01 |
| AfricanAmerican-vs-Asian |
1.911640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956890E-03 |
| Normal-vs-Female |
7.360800E-03 |
| Male-vs-Female |
4.478200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.074000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.977000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.555500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.614420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.328600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.207400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.953800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.743400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.561600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.035600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.217220E-01 |
| Classical-VS-Follicular |
9.034300E-02 |
| Classical-VS-Other |
1.609780E-01 |
| Classical-VS-Normal |
3.338300E-02 |
| Tall-VS-Follicular |
8.010800E-01 |
| Tall-VS-Other |
5.742800E-01 |
| Tall-VS-Normal |
7.743900E-03 |
| Follicular-VS-Other |
5.196600E-01 |
| Follicular-VS-Normal |
4.944600E-03 |
| Other-VS-Normal |
3.310200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.362500E-03 |
| Normal-vs-N1 |
8.774000E-04 |
| N0-vs-N1 |
3.535000E-01 |
|
|
